Δ9-Tetrahydrocannabinol Decreases Cytotoxic T Lymphocyte Activity to Herpes Simplex Virus Type 1-Infected Cells (43452)

Proceedings of the Society for Experimental Biology and Medicine

Volumn 200, Issue 3, 1992, Pages 422-430

  Fischer Stenger, K ^a   Updegrove, Alan W ^a   Cabral, G A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HELPER CELL; HERPES SIMPLEX VIRUS 1; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MICROSCOPY; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL; VIRUS INFECTION;

ANIMAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; LEUKOCYTE COUNT; MICE; MICE, INBRED C3H; MICROSCOPY; MICROSCOPY, FLUORESCENCE; SIMPLEXVIRUS; SPLEEN; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TETRAHYDROCANNABINOL;

EID: 0026623545     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-200-43452     Document Type: Article

References (52)

1. Blanchard DK, Newton C, Klein TW, Stewart WE II, Friedman H. In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Int J Immunopharmacol 8:819–824, 1986.
2. Cabral GA, McNerney PJ, Mishkin EM. Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2. Immunopharmacol Immunotoxicol 9:361–370, 1987.
3. Cabral GA, Mishkin EM. Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. J Toxicol Environ Health 26:175–182, 1989.
4. Cabral GA, Mishkin EM, Marciano-Cabral F, Coleman P, Harris L, Munson AE. Effect of Delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infections in the guinea pig. Proc Soc Exp Biol Med 182:181–186, 1986.
5. Klein TW, Newton C, Friedman H. Inhibition of natural killer cell function by marijuana components. J Toxicol Environ Health 20:321–332, 1987.
6. Klein TW, Newton CA, Widen R, Friedman H. The effect of delta-9-tetrahydrocannabinol on T lymphocyte and B lymphocyte mitogen responses. J Immunopharmacol 7:451–466, 1985.
7. Lopez-Cepero M, Friedman M, Klein T, Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J Leukocyte Biol 39:679–686, 1986.
8. 1 mouse. J Gen Virol 66:2539–2549, 1985.
9. Morahan PS, Klykken PC, Smith SH, Harris LS, Munson AE. Effects of cannabinoids on host resistance to Listeria monocytogens and herpes simplex virus. Infect Immun 23:670–674, 1979.
10. Nahas GG, Sucia-Foca N, Arwand SP, Morishima A. Inhibition of cellular mediated immunity in marihuana smokers. Science 183:419–420, 1974.
11. Pross SH, Klein TW, Newton C, Friedman H. Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitro. Int J Immunopharmacol 9:363–370, 1987.
12. Pross SH, Klein TW, Newton CA, Smith J, Widen R, Friedman H. Differential suppression of T-cell subpopulations by THC (delta-9-tetrahydrocannabinol). Int J Immunopharmacol 12:539–544, 1990.
13. Specter SC, Klein TW, Newton C, Mondragon M, Widen R, Friedman H. Marijuana effects on immunity: Suppression of human natural killer cell activity by delta-9-tetrahydrocannabinol. Int Soc Immunopharmacol 8:741–745, 1986.
14. Glasser M, Law LW. T-T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice. Nature 273:385–387, 1978.
15. Lawman MJP, Rouse BT, Courtney RJ, Walker RD. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect Immun 27:133–139, 1980.
16. Sethi KK, Brandis H. Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 and 2. Immunobiology 150:162–173, 1977.
17. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature 248:701–702, 1974.
18. Germain RN, Dorf ME, Benacerraf B. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor. J Exp Med 142:1023–1028, 1975.
19. Schrader JW, Edelman GM. Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells. J Exp Med 143:601–614, 1976.
20. Burakoff SJ, Engelhard VH, Kaufman J, Strominger JL. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens. Nature 283:495–497, 1980.
21. Cerottini JC, Brunner KT. Cell mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 18:67–132, 1974.
22. Berke G. Lymphocyte-mediated cytolysis. Effectors, lytic signals, and the mechanism whereby early membrane derangements result in target-cell death. Ann NY Acad Sci 532:314–335, 1988.
23. Geiger B, Rosen D, Berke G. Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target areas. J Cell Biol 95:137–143, 1982.
24. Kupfer A, Dennert G. Reorientation of the microtubule-organizing center and the Golgi apparatus in cloned cytotoxic lymphocytes triggered by binding to lysable target cells. J Immunol 133:2762–2766, 1984.
25. Kupfer A, Dennert G, Singer SJ. Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets. Proc Natl Acad Sci USA 80:7224–7228, 1983.
26. Yannelli JR, Sullivan JA, Mandell GL, Engelhard VH. Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography. J Immunol 136:377–382, 1986.
27. Engelhard VH, Gnarra JR, Sullivan J, Mandell GL, Gray LS. Early events in target-cell lysis by cytotoxic T cells. Ann NY Acad Sci 532:303–313, 1988.
28. Mishell BB, Shiigi SM, Henry C, Chan EL, North J, Gallily R, Slomich M, Miller K, Marbrook J, Parks D, Good AH. Determination of viability by trypan blue exclusion. In: Mishell BB, Shiigi SM, Eds. Selected Methods in Cellular Immunology. San Francisco: WH Freeman, pp 16–17, 1980.
29. Rapp F. Variants of herpes simplex virus: Isolation, characterization, and factors influencing plaque formation. J Bacteriol 86:985–991, 1963.
30. Mosier DE. Separation of murine macrophages by adherence to solid substrates. In: Adams DO, Edelson PJ, Koren H, Eds. Methods for Studying Mononuclear Phagocytes. New York: Academic Press, pp 179–186, 1981.
31. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 poly-Proc Natl Acad Sci USA 84:1374–1378, 1987.
32. Blanden RV. T cell response to viral and bacterial infection. Transplant Rev 19:56–88, 1974.
33. Kreth HW, ter Meulen V, Eckert G. Demonstration of HLA restricted killer cells in patients with acute measles. Med Microbiol Immun 165:203–214, 1979.
34. Lin L-Y, Askonas BA. Cross-reactivity for different type A influenza viruses of a cloned T killer cell line. Nature 288:164–165, 1980.
35. North RJ. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 7:166–176, 1973.
36. Rouse BT, Lawman M. Induction of cytotoxic T lymphocytes against herpes simplex virus type 1: Role of accessory cells and amplifying factor. J Immunol 124:2341–2346, 1980.
37. Schmid DS, Rouse BT. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: Differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors. J Immunol 131:479–484, 1983.
38. Tsutsumi H, Chiba Y, Abo W, Chiba S, Nakoo T. T-cell-mediated cytotoxic response to mumps virus in humans. Infect Immun 30:129–134, 1980.
39. Yap KL, Ada GL. The recovery of mice from influenza A virus infection: Adoptive transfer of immunity with immune T lymphocytes. Scand J Immunol 7:389–397, 1978.
40. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function, and responsiveness. Adv Immunol 27:51–177, 1979.
41. Martz E. Mechanism of specific tumor cell lysis by alloimmune T-lymphocytes: Resolution and characterization of discrete steps in the cellular interaction. Contemp Top Immunobiol 7:301–361, 1977.
42. Morahan PS, Morse SS, McGeorge MB. Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol 46:291–300, 1980.
43. Cabral GA, Vasquez R. Effects of marihuana on macrophage function. In: Friedman H, Specter S, Klein T, Eds. Drugs of Abuse, Immunity, and Immunodeficiency. New York: Plenum Press, pp 93–105, 1991.
44. Leopardi E, Friend DS, Rosenau W. Target cell lysis: Ultrastructural and cytoskeletal alterations. J Immunol 133:3429–3436, 1984.
45. Golstein P. Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity. Nature 252:81–83, 1974.
46. Zagury D. Direct analysis of individual killer T cells: Susceptibility of target cells to lysis and secretion of hydrolytic enzymes by CTL. Adv Exp Med Biol 146:149–169, 1982.
47. Abercrombie M, Heaysman JEM, Pegrum SM. The locomotion of fibroblasts in culture. III: Movements of particles on the dorsal surface of the leading lamella. Exp Cell Res 62:389–398, 1970.
48. Bergman JE, Kupfer A, Singer SJ. Membrane insertion at the leading edge of motile fibroblasts. Proc Natl Acad Sci USA 80:1367–1371, 1983.
49. Meyers WA, Heath RG. Cannabis sativa: Ultrastructural changes in organelles and neurons in brain septal region of monkeys. J Neurosci Res 4:9–17, 1979.
50. Poddar MK, Mittra G, Ghosh JJ. Delta-9-tetrahydrocannabinol-induced changes in brain ribosomes. Toxicol Appl Pharmacol 46:737–757, 1978.
51. Cabral GA, McNerney PJ, Mishkin EM. Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells. Arch Toxicol 60:438–449, 1987.
52. Wing DR, Leuschner JTA, Brent GA, Harvey DJ, Paton WDM. Quantification of in vivo membrane associated delta-9-tetrahydrocannabinol and its effect on membrane fluidity. In: Harvey DJ, Ed. Proceedings of the 9th International Congress of Pharmacology 3rd Satellite Symposium on Cannabis. Oxford: IRL Press, pp 411–418, 1985.